CARDIFF ONCOLOGY INC. - COMMON STOCK

Cardiff Oncology Reports First Quarter 2025 Results and Provides Business Update

08 May 2025 13:05:02 By Nasdaq GlobeNewswire

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

23 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

15 Apr 2025 13:10:00 By Nasdaq GlobeNewswire

Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

15 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

27 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology to Present at Upcoming Investor Conferences

24 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update

20 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering

10 Dec 2024 04:20:00 By Nasdaq GlobeNewswire

Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial

10 Dec 2024 03:00:00 By Nasdaq GlobeNewswire

Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC

19 Nov 2024 05:00:01 By Nasdaq GlobeNewswire

Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update

07 Nov 2024 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC

30 Oct 2024 13:30:00 By Nasdaq GlobeNewswire

Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update

08 Aug 2024 13:05:01 By Nasdaq GlobeNewswire

Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update

01 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology to Present at the Jefferies Healthcare Conference

29 May 2024 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology to Present at Upcoming Investor Conferences in May

13 May 2024 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update

02 May 2024 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update

25 Apr 2024 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

08 Apr 2024 13:05:00 By Nasdaq GlobeNewswire

Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024

06 Mar 2024 13:05:00 By Nasdaq GlobeNewswire